Intensive Monitoring of Renal Function
Association Between Intensive Monitoring of Renal Function and Outcomes in Critically Ill Patients
1 other identifier
observational
15,724
0 countries
N/A
Brief Summary
This study aims to examine the association between monitoring (Intensive and non-intensive) of renal function (urine output, serum creatinine) and outcomes among critically ill patients such as Acute Kidney Injury (AKI) and mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2015
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 29, 2015
CompletedFirst Posted
Study publicly available on registry
January 15, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2017
CompletedResults Posted
Study results publicly available
June 28, 2019
CompletedJune 28, 2019
June 1, 2019
2 years
September 29, 2015
September 30, 2017
June 20, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Detection of Acute Kidney Injury (AKI)
We classified AKI according to the maximum Kidney Disease Improving Global Outcomes criteria met during the 7 days after ICU admission using both SC and UO criteria. Admission creatinine levels were the first creatinine value recorded for the index hospital admission. Reference creatinine level was taken as the baseline creatinine level when available; otherwise, it was the lowest between admission creatinine level or creatinine level recorded in the 24 hours following ICU admission estimated using MDRD equation. For all analyses, we used moderate to severe AKI defined as stage 2-3. For UO criteria, at least every 6 hours data was required to stage AKI regardless of whether the patient had intensive or nonintensive UO monitoring overall.Odds ratio were measured between two groups.Odds ratios were determined using multivariable models for intensive vs non-intensive UO and between intensive vs non-intensive creatinine monitoring groups.
7 days from ICU admission
Secondary Outcomes (3)
Mortality
30 days
Length of Stay in ICU
30 days
Hospital Length of Stay
30 days
Study Arms (2)
Intensive Monitoring of Renal Function
Urine output measurements recorded at least every 2 hours within the first 48 hours of ICU admission and serum creatinine measurements recorded daily for 3 days following ICU admission.
Less-Intensive Monitoring of Renal Function
Urine output measurements with gaps of more than 3 hours recorded during the first 48 hours of ICU admission and fewer than 3 days of serum creatinine measurements after ICU admission.
Eligibility Criteria
Adult patients admitted at the University of Pittsburgh Medical Center ICU or hospital.
You may qualify if:
- Critically ill patient admitted to ICU
- Required vasopressor support or mechanical ventilation in the 24 hours from ICU admission
You may not qualify if:
- History of chronic dialysis and/or renal transplant
- Baseline serum creatinine \>= 4 mg/dl
- Insufficient data to determine AKI stage in the 7 days from ICU admission
- Died within 48 hours from ICU admission
- ICU duration \<2880 minutes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- C. R. Bardcollaborator
Related Publications (1)
Jin K, Murugan R, Sileanu FE, Foldes E, Priyanka P, Clermont G, Kellum JA. Intensive Monitoring of Urine Output Is Associated With Increased Detection of Acute Kidney Injury and Improved Outcomes. Chest. 2017 Nov;152(5):972-979. doi: 10.1016/j.chest.2017.05.011. Epub 2017 May 17.
PMID: 28527880RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
This is a retrospective observational study.
Results Point of Contact
- Title
- Dr. John Kellum
- Organization
- The University of Pittsburgh
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Center for Critical Care Nephrology; Professor, Critical Care Medicine
Study Record Dates
First Submitted
September 29, 2015
First Posted
January 15, 2016
Study Start
January 1, 2015
Primary Completion
January 1, 2017
Study Completion
May 1, 2017
Last Updated
June 28, 2019
Results First Posted
June 28, 2019
Record last verified: 2019-06